Accelrys
Accelrys develops and commercializes scientific business intelligence software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data. They are a NASDAQ-listed public company (ACCL) that combines financial stability and a strong market position. They offer high-quality service around the globe.
Accelrys combines experience and intellectual property developed during twenty-five years of serving research organizations with modeling and simulation, bioinformatics, cheminformatics, and middleware technology. Accelrys was founded in 2001, bringing together five specialist companies Molecular Simulations Inc. (MSI), Synopsys Scientific Systems, Oxford Molecular, the Genetics Computer Group (GCG), and Synomics Ltd. Establishing working relationships with customers in order to better understand their needs helps Accelrys develop leading-edge technology that can keep pace with needs of the scientific and clinical research communities and directly address critical pain points and technology limitation that are affecting their customers’ business.
For more information, please visit http://accelrys.com